Status:
COMPLETED
Integrated Behavioral Therapy for Treating Children With Selective Mutism
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Selective Mutism
Eligibility:
All Genders
4-8 years
Phase:
NA
Brief Summary
This study will determine the effectiveness of integrated behavior therapy in treating children with selective mutism.
Detailed Description
Selective mutism (SM) is a childhood behavior disorder that interferes with social and educational development. It is characterized by a persistent failure to speak in specific social situations, desp...
Eligibility Criteria
Inclusion
- Diagnosis of selective mutism
- Score of less than 60 on the Childrens Global Assessment Scale (CGAS)
- Has lived continuously with a primary caretaker who has known the child well for at least 6 months prior to study entry and is legally able to sign the consent form
Exclusion
- Diagnosis of any of the following psychiatric disorders: bipolar disorder, pervasive developmental disorder (e.g., Asperger's, autism), mental retardation, or psychotic disorder
- Possibility that a communication disorder may account for the selective mutism
- Current use of or a clinical indication for use of psychotropic medication (youth entering study on a stable psychostimulant regimen for ADHD will not be excluded)
- History of unsuccessful treatment with cognitive behavioral therapy for anxiety that occurred within 2 years prior to study entry
- Any major neurological disorder or major medical illness that may prevent study participation
- Child and/or parent is not English-speaking and is unable to complete measures or treatment without the assistance of a dedicated translator
- Child is not currently attending school (including pre-school), day camp, or other structured daily activity, or has missed more than 50% of school days in the 2 months prior to study entry
- Child's primary teacher is unwilling or unable to participate in the treatment plan
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00458198
Start Date
January 1 2006
End Date
June 1 2009
Last Update
November 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
300 UCLA Medical Plaza
Los Angeles, California, United States, 90095